Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
French Health Officials Urge Women to Remove
Faulty Breast Implant
Women with a type of French-made breast implant prone to leakage should
have them removed as a safety precaution, French health officials said
Friday.
No increased cancer risk has been detected from rupture of the devices,
which were implanted in thousands of women in Europe, but leakage can
cause inflammation, the French health ministry said in a statement, the
Wall Street Journal reported. Leakage also makes removal difficult,
the newspaper said.
Women with the implants should have them removed in a “non urgent
manner,” the officials advised. Those who decide to keep the implants
should undergo breast scans twice a year, the Journal said.
“Implant failures” have been reported for about 5 percent of women in
France with the devices, made by Poly Implant Prosthese (PIP), according
to the Journal. The company went into bankruptcy last year because
of the ruptures.
In Britain, where 1 percent of women with PIP implants have experienced
such “failures,” health officials said several days ago they saw no reason
to call for routine removal of the devices.
—–
Wal-Mart Pulls Infant Formula From Stores
After Newborn’s Death
A batch of Enfamil Newborn powdered infant formula has been removed
from more than 3,000 Wal-Mart stores in the United States after a newborn
who consumed the formula died.
Health officials have not yet determined if the infant’s death is
linked to the formula and there is no recall. But Wal-Mart decided to
remove 12.5-ounce cans of the powdered infant formula with the lot number
ZP1K7G from its shelves “out of an abundance of caution,” company
spokeswoman Dianna Gee told the Associated Press.
The 10-day-old Missouri boy became seriously ill with a suspected
bacterial infection and died after he was taken off life support. Samples
of the formula consumed by the infant were sent to the U.S. Centers for
Disease Control and Prevention and the Food and Drug Administration for
testing. The manufacturer said tests showed no traces of the bacteria in
the batch before it was shipped, the news service said.
“At this point it has not been determined whether the illness is linked
to the formula or an outside source,” Gena Terlizzi, spokeswoman for the
Missouri Department of Health and Senior Services, said in a statement,
the AP reported.
—–
Motrin Coated Caplets Recalled
Batches of Motrin coated caplets that were distributed in the United
States and a number of other countries have been recalled, Johnson
Johnson announced Wednesday.
The company said “testing of product samples showed that some caplets
may not dissolve as quickly as intended when nearing their expiration
date,” CNN reported.
The pain reliever caplets were distributed in the U.S., Puerto Rico,
Bahamas, Belize, Fiji, Jamaica and St. Lucia.
“This is not a consumer level recall, which means that consumers do not
need to dispose of or return the product,” according to a news release
from JJ’s McNeil Consumer Healthcare Division, CNN
reported.
“There is no safety concern if consumers continue taking the product in
accordance with its label; however, it is possible there may be a delay in
experiencing relief,” the company said.
—–
Related posts:
Views: 0